Predicting Rectal Cancer Treatment Response with MRI and Machine Learning
Author Information
Author(s): Filippo Crimì, Carlo D’Alessandro, Chiara Zanon, Francesco Celotto, Christian Salvatore, Matteo Interlenghi, Isabella Castiglioni, Emilio Quaia, Salvatore Pucciarelli, Gaya Spolverato, Andrew Edet Ekpenyong
Primary Institution: University of Padova
Hypothesis
Can a machine learning model based on MRI radiomics predict the response to chemoradiation in rectal cancer patients?
Conclusion
The study demonstrates that radiomics and machine learning can effectively predict treatment response in rectal cancer patients.
Supporting Evidence
- The best-performing model achieved a ROC-AUC of 73% and an accuracy of 70%.
- In the validation cohort, the model showed a sensitivity of 81% and specificity of 75%.
- High sensitivity and positive predictive value (PPV) were observed, indicating good accuracy in detecting non-responders.
Takeaway
Doctors can use special computer programs to look at MRI pictures of rectal cancer to see how well treatment is working.
Methodology
The study used MRI data from 102 patients, dividing them into training and validation cohorts, and applied machine learning models to predict treatment response.
Potential Biases
Potential observer variability due to manual segmentation by radiologists.
Limitations
The study was monocentric with a limited patient cohort and used manual segmentation, which may introduce variability.
Participant Demographics
Median age of participants was 64 years, with 58 men (56.8%) and 44 women (43.2%).
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website